Drugs / Gentamicins
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04789928 | Jan 2021 → Dec 2023 | — | Institut Pasteur | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gentamicins | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04789928 ↗ |
| Route | Other | “Patients included in this study will receive daily injection (up to 10 days) of genta-EDTA-Na2 lock associated with systemic antibiotics.” NCT04789928 ↗ |